Immunotherapies in Lung Cancer | 2022 Evolution Conference

The availability of immunotherapies, such as checkpoint inhibitor drugs, has been transformative across many different cancer types. In this session, Dr Ibiayi Dagogo-Jack from Mass General Cancer Center discusses how these therapies are helping to reshape treatment paradigms in the lung cancer setting.
To obtain credit for this CME activity you must watch the full 2022 Evolution Conference Playlist. Information on obtaining CME/CE Credits and MOC points can be found in the playlist description.